Received: 12 April 2021
Accepted: 6 July 2021
First Online: 17 July 2021
: The study was approved by our ethics committee on July 17, 2018 (CPP Ile de France 1, ID-RCB: 2018-A01288-47) and was registered on ClinicalTrial.gov on July 24, 2018 (#NCT03600181). Informed consent was obtained from each patient or proxy before study inclusion.
: Not applicable.
: The Rad7 monitors and Rainbow SET devices were provided free of charge by Masimo Inc., Irvine, CA. Masimo Inc. had no role in the study design or conduct; data collection, management, analysis, or interpretation; preparation, review, or approval of the manuscript; or decision to submit the manuscript for publication.